litlas
Log inCreate account

Won Ki Kang

Active 1993–2025

Also published as
Won-Ki Kang
99
Papers
20,264
Citations
70
h-index
97
i10-index

Citations

Citations per year for Won Ki Kang1994: 1 citations1997: 1 citations1998: 2 citations1999: 7 citations2000: 12 citations2001: 7 citations2002: 14 citations2003: 14 citations2004: 24 citations2005: 29 citations2006: 39 citations2007: 33 citations2008: 53 citations2009: 39 citations2010: 48 citations2011: 47 citations2012: 54 citations2013: 75 citations2014: 106 citations2015: 120 citations2016: 110 citations2017: 139 citations2018: 204 citations2019: 812 citations2020: 1,030 citations2021: 978 citations2022: 839 citations2023: 650 citations2024: 917 citations2025: 480 citations2026: 18 citations1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 1,865 citing papers, 23.7% of this breakdownUnited States: 1,380 citing papers, 17.6% of this breakdownJapan: 639 citing papers, 8.1% of this breakdownSouth Korea: 518 citing papers, 6.6% of this breakdownItaly: 383 citing papers, 4.9% of this breakdownUnited Kingdom: 371 citing papers, 4.7% of this breakdownGermany: 317 citing papers, 4% of this breakdownFrance: 194 citing papers, 2.5% of this breakdownSpain: 178 citing papers, 2.3% of this breakdownNetherlands: 158 citing papers, 2% of this breakdownCanada: 156 citing papers, 2% of this breakdownSingapore: 112 citing papers, 1.4% of this breakdown
0%23.7%Other 20.2%

Institutions

Fields

  • Medicine69.9%
  • Biochemistry, Genetics and Molecular Biology23.1%
  • Immunology and Microbiology3.9%
  • Neuroscience1.2%
  • Computer Science0.5%
  • Engineering0.4%
  • Other1%

Topics

  • Gastric Cancer Management and Outcomes9.2%
  • Cancer Immunotherapy and Biomarkers9%
  • Ferroptosis and cancer prognosis3%
  • Cancer Genomics and Diagnostics2.8%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.8%
  • Gastrointestinal Tumor Research and Treatment2.8%
  • Other70.4%

Coauthors

All papers

Open in search
  1. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

    Authors: Seung Tae Kim, Răzvan Cristescu, Adam J. Bass, Kyoung‐Mee Kim, Justin I. Odegaard, Kyung Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mi-Jin Lee, Sujin Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Hyuk Lee, Min Gew Choi, AmirAli Talasaz, Peter Kang, Jonathan D. Cheng, Andrey Loboda, Jeeyun Lee, Won Ki Kang - Nature Medicine 2018 cited by 1,717

  2. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

    Authors: Răzvan Cristescu, Jeeyun Lee, Michael Nebozhyn, Kyoung‐Mee Kim, Jason C. Ting, Swee Seong Wong, Jiangang Liu, Yong Yue, Jian Wang, Kun Yu, Xiang S. Ye, In‐Gu Do, X. Shawn Liu, Lara Gong, Jake Fu, Jason Jin, Min Gew Choi, Tae Sung Sohn, Joon Ho Lee, Jae Moon Bae, Seung Tae Kim, Se Hoon Park, Insuk Sohn, Sin‐Ho Jung, Patrick Tan, Ronghua Chen, James C.H. Hardwick, Won Ki Kang, Mark Ayers, Dai Hongyue, Christoph Reinhard, Andrey Loboda, Sung Kim, Amit Aggarwal, Sung Kim, Amit Aggarwal - Nature Medicine 2015 cited by 2,244

  3. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh, Min‐Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, Li‐Tzong Chen - The Lancet 2017 cited by 2,279

  4. Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability–High Gastric Cancer

    Authors: Minsuk Kwon, Minae An, Samuel J. Klempner, Hyuk Lee, Kyoung‐Mee Kim, K. Jason, Hee Jin Cho, Jung Yong Hong, Taehyang Lee, Yang Won Min, Tae Jun Kim, Byung‐Hoon Min, Woong‐Yang Park, Won Ki Kang, Kyu‐Tae Kim, Seung Tae Kim, Jeeyun Lee - Cancer Discovery 2021 cited by 241

  5. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

    Authors: Filippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, Young‐Woo Kim, Won Ki Kang, Ruth E. Langley, Yoon Young Choi, Kyoung-Mee Kim, Matthew Nankivell, Federica Morano, Andrew Wotherspoon, Nicola Valeri, Myeong‐Cherl Kook, Ji Yeong An, Heike I. Grabsch, Giovanni Fucà, Sung Hoon Noh, Tae Sung Sohn, Sung Kim, Maria Di Bartolomeo, David Cunningham, Jeeyun Lee, Jae‐Ho Cheong, Elizabeth Smyth - Journal of Clinical Oncology 2019 cited by 474

  6. Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer

    Authors: Ryul Kim, Minae An, Hyuk Lee, Arnav Mehta, You Jeong Heo, Kyoung-Mee Kim, Song-Yi Lee, Jeonghyeon Moon, Seung Tae Kim, Byung-Hoon Min, Tae Jun Kim, Sun Young Rha, Won Ki Kang, Woong-Yang Park, Samuel J. Klempner, Jeeyun Lee - Cancer Discovery 2021 cited by 175

  7. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project

    Authors: Bo Hwa Sohn, Jun‐Eul Hwang, Hee-Jin Jang, Hyun‐Sung Lee, Sang Cheul Oh, Jae‐Jun Shim, Keun‐Wook Lee, Eui Hyun Kim, Sun Young Yim, Sang Ho Lee, Jae‐Ho Cheong, Woojin Jeong, Y. Choi, Joo‐Hee Kim, Jungsoo Chae, Jeeyun Lee, Won Ki Kang, Sung Kim, Sung Hoon Noh, Jaffer A. Ajani, Ju‐Seog Lee - Clinical Cancer Research 2017 cited by 479

  8. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype

    Authors: Sang Cheul Oh, Bo Hwa Sohn, Jae‐Ho Cheong, Sang-Bae Kim, Jae Eun Lee, Ki Cheong Park, Sang Ho Lee, Jong‐Lyul Park, Yun-Yong Park, Hyun‐Sung Lee, Hee-Jin Jang, Eun Sung Park, Sang-Cheol Kim, Jeonghoon Heo, In‐Sun Chu, You Jin Jang, Young‐Jae Mok, Wonkyung Jung, Baek‐hui Kim, Aeree Kim, Y. Choi, Jae Yun Lim, Yuki Hayashi, Shumei Song, Elena Elimova, Jeannelyn S. Estralla, Jeffrey H. Lee, Manoop S. Bhutani, Yiling Lu, Wenbin Liu, Jeeyun Lee, Won Ki Kang, Sung Hoon Kim, Sung Hoon Noh, Gordon B. Mills, Seon‐Young Kim, Jaffer A. Ajani, Ju‐Seog Lee, Seon‐Young Kim, Jaffer A. Ajani, Ju‐Seog Lee, Ju‐Seog Lee - Nature Communications 2018 cited by 464

  9. Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer

    Authors: Jung Yong Hong, Ji Yeong An, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung‐Mee Kim, Won Ki Kang, Seung Tae Kim - Translational Cancer Research 2020 cited by 93

  10. Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial

    Authors: Jeeyun Lee, Seung Tae Kim, Kyung Kim, Hyuk Lee, Iwanka Kozarewa, Peter G. Mortimer, Justin I. Odegaard, Elizabeth A. Harrington, Ju-Young Lee, Taehyang Lee, Sung Yong Oh, Jung-Hun Kang, Jung Hoon Kim, Youjin Kim, Jun Ho Ji, Young Saing Kim, Kyoung Eun Lee, Jinchul Kim, Tae Sung Sohn, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Jae J. Kim, Yang Won Min, Byung‐Hoon Min, Nayoung K. D. Kim, Sally Luke, Young Hwa Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, AmirAli Talasaz, Simon J. Hollingsworth, Kyoung‐Mee Kim, Won Ki Kang - Cancer Discovery 2019 cited by 234

  11. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer

    Authors: Minsuk Kwon, Gahyun Kim, Ryul Kim, Kyu‐Tae Kim, Seung Tae Kim, Simon A. Smith, Peter G. Mortimer, Jung Yong Hong, Arsène‐Bienvenu Loembé, Itziar Irurzun‐Arana, Loumpiana Koulai, Kyoung‐Mee Kim, Won Ki Kang, Emma Dean, Woong‐Yang Park, Jeeyun Lee - Journal for ImmunoTherapy of Cancer 2022 cited by 89

  12. Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer

    Authors: Sujin Hyung, Jihoon Ko, You Jeong Heo, Steven M. Blum, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Won Ki Kang, Ho Yeong Lim, Samuel J. Klempner, Jeeyun Lee - Science Advances 2023 cited by 43

  13. Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

    Authors: Shukui Qin, Yuxian Bai, Ho Yeong Lim, Sumitra Thongprasert, Yee Chao, Jia Fan, Tsai‐Shen Yang, Vajarabhongsa Bhudhisawasdi, Won Ki Kang, Yu Zhou, Jee Hyun Lee, Yan Sun - Journal of Clinical Oncology 2013 cited by 507

  14. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

    Authors: S.H. Park, D.H. Lim, Tae Sung Sohn, J. Lee, Dae Young Zang, S.T. Kim, Jung Hun Kang, Sung Yong Oh, In Gyu Hwang, Jun Ho Ji, D.B. Shin, Jeong Il Yu, K.-M. Kim, Ji Yeong An, M.G. Choi, J.H. Lee, S. Kim, Jung Yong Hong, Joon Oh Park, Y.S. Park, Ho Yeong Lim, Jae Moon Bae, Won Ki Kang - Annals of Oncology 2020 cited by 286

  15. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

    Authors: Li‐Tzong Chen, Taroh Satoh, Min‐Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, Hiroki Sameshima, Yoon‐Koo Kang, Narikazu Boku - Gastric Cancer 2019 cited by 231

  16. FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival

    Authors: Soomin Ahn, Jeeyun Lee, Min Eui Hong, Seung Tae Kim, Se Hoon Park, Min Gew Choi, Junho Lee, Tae Sung Sohn, Jae Moon Bae, Sung Kim, Sin‐Ho Jung, Won Ki Kang, Kyoung‐Mee Kim - Modern Pathology 2016 cited by 114

  17. Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

    Authors: Minae An, Arnav Mehta, Byung‐Hoon Min, You Jeong Heo, Samuel J. Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J. Park, Matthew R. Strickland, Woong‐Yang Park, Won Ki Kang, Kyoung‐Mee Kim, Seung Tae Kim, Samuel J. Klempner, Jeeyun Lee - Cancer Discovery 2024 cited by 51

  18. Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab

    Authors: Narikazu Boku, Taroh Satoh, Min‐Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, Taihei Nishiyama, Li‐Tzong Chen, Yoon‐Koo Kang - Gastric Cancer 2021 cited by 123

  19. Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer

    Authors: Seung Tae Kim, Simon A. Smith, Peter G. Mortimer, Arsène‐Bienvenu Loembé, Heejin Cho, Kyoung‐Mee Kim, Claire Smith, Sophie E. Willis, Itziar Irurzun‐Arana, Aliénor Berges, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Iwanka Kozarewa, Andrew J. Pierce, Emma Dean, Jeeyun Lee - Clinical Cancer Research 2021 cited by 79

  20. Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer

    Authors: Se Hoon Park, Caroline J. Breitbach, Jeeyun Lee, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Anne Moon, Jae-Hee Mun, Erica M. Sommermann, Liliana Maruri Avidal, Rick Patt, Adina Pelusio, James M. Burke, Tae-Ho Hwang, David H. Kirn, Young Suk Park - Molecular Therapy 2015 cited by 180

  21. Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study

    Authors: Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, In Gyu Hwang, Sang‐Cheol Lee, Keon Woo Park, Hyo Rak Lee, Won Ki Kang - European Journal of Cancer 2014 cited by 113

  22. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

    Authors: Yoon‐Koo Kang, Won Ki Kang, D.B. Shin, Jingyu Chen, Jianping Xiong, Jie Wang, Mikhail Lichinitser, Z. Guan, Р. Ш. Хасанов, Leizhen Zheng, Manuel Jesus Philco-Salas, T. Suarez, Javier Gutiérrez Santamarı́a, Gerhard Förster, P. McCloud - Annals of Oncology 2009 cited by 777

  23. Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial

    Authors: Jeeyun Lee, Do Hoon Lim, Sung Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Min Gew Choi, Tae Sung Sohn, Jae Hyung Noh, Jae Moon Bae, Yong Chan Ahn, Insuk Sohn, Sin Ho Jung, Cheol Keun Park, Kyoung‐Mee Kim, Won Ki Kang - Journal of Clinical Oncology 2011 cited by 812

  24. Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

    Authors: Jung Hun Kang, Soon Il Lee, Do Hyoung Lim, Keon Woo Park, Sung Yong Oh, Hyuk‐Chan Kwon, In Gyu Hwang, Sang‐Cheol Lee, Eunmi Nam, Dong Bok Shin, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park - Journal of Clinical Oncology 2012 cited by 672